Literature DB >> 11981740

Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole.

Amar Safdar1.   

Abstract

A case of rapidly progressive cutaneous infection due to Paecilomyces lilacinus developed in a woman with advanced pancreatic cancer who did not have granulocytopenia. The infection responded favorably to caspofungin and itraconazole combination therapy.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11981740     DOI： 10.1086/340260

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  5 in total

Review 1.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

2.  Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Maria J Buitrago; Araceli Monzon; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

3.  Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.

Authors:  D J Diekema; S A Messer; R J Hollis; R N Jones; M A Pfaller
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 4.  Paecilomyces lilacinus vaginitis in an immuno-competent patient.

Authors:  Jeanne Carey; Ron D'Amico; Deanna A Sutton; Michael G Rinaldi
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

5.  Scedosporium apiospermum infections and the role of combination antifungal therapy and GM-CSF: A case report and review of the literature.

Authors:  Chloe Goldman; Matthew J Akiyama; Julian Torres; Eddie Louie; Shane A Meehan
Journal:  Med Mycol Case Rep       Date:  2016-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.